Novo and Lilly just slashed prices on GLP-1 weight-loss drugs that recently cost over $1,000 a month. What happened?
The weight-loss drug eloralintide shows up to 20% body weight reduction in trial, offering hope for obesity treatment beyond ...
Novo Nordisk said an older version of its weight-loss drug semaglutide failed to meet its main goal in late-stage trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback